# Effect of Ropinirole Hydrochloride in Progressive Myoclonic Epilepsy of Unverricht-Lundborg Type

> **NCT00639119** · PHASE2 · UNKNOWN · sponsor: **University of Turku** · enrollment: 16 (estimated)

## Conditions studied

- Unverricht-Lundborg Syndrome

## Interventions

- **DRUG:** Ropinirole

## Key facts

- **NCT ID:** NCT00639119
- **Lead sponsor:** University of Turku
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-08
- **Primary completion:** 2008-08
- **Final completion:** —
- **Target enrollment:** 16 (ESTIMATED)
- **Last updated:** 2008-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00639119

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00639119, "Effect of Ropinirole Hydrochloride in Progressive Myoclonic Epilepsy of Unverricht-Lundborg Type". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00639119. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*